Skip to content
10-Q

Quarterly Report

ACHILLION PHARMACEUTICALS INC

0001193125-19-216792

← back to feed
Filed
Aug 8, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2019 · Aug 1, 2019 139.69M sh
Capex Q2 2019 · Jun 30, 2019 $91K
Capex Q2 2019 · Jun 30, 2018 $352K
Operating Cash Flow Q2 2019 · Jun 30, 2019 −$31.8M
Operating Cash Flow Q2 2019 · Jun 30, 2018 −$37.31M
Cash And Equivalents Q2 2019 · Jun 30, 2019 $34.88M
Cash And Equivalents Q2 2019 · Dec 31, 2018 $49.83M
Stockholders Equity Q2 2019 · Jun 30, 2019 $231.64M
Stockholders Equity Q2 2019 · Mar 31, 2019 $248.94M
Stockholders Equity Q2 2019 · Dec 31, 2018 $266.01M
Stockholders Equity Q2 2019 · Jun 30, 2018 $294.56M
Stockholders Equity Q2 2019 · Mar 31, 2018 $307.27M
Stockholders Equity Q2 2019 · Dec 31, 2017 $324.52M
Current Liabilities Q2 2019 · Jun 30, 2019 $16.22M
Current Liabilities Q2 2019 · Dec 31, 2018 $11.83M
Total Liabilities Q2 2019 · Jun 30, 2019 $16.73M
Total Liabilities Q2 2019 · Dec 31, 2018 $11.85M
Current Assets Q2 2019 · Jun 30, 2019 $237.51M
Current Assets Q2 2019 · Dec 31, 2018 $275.38M
Total Assets Q2 2019 · Jun 30, 2019 $248.38M
Total Assets Q2 2019 · Dec 31, 2018 $277.86M
Sga Expense Q2 2019 · Jun 30, 2019 $5.11M
Sga Expense Q2 2019 · Jun 30, 2019 $10.27M
Sga Expense restated Q2 2019 · Jun 30, 2018 $7.46M
Sga Expense restated Q2 2019 · Jun 30, 2018 $13.48M
Rd Expense Q2 2019 · Jun 30, 2019 $15.93M
Rd Expense Q2 2019 · Jun 30, 2019 $30.75M
Rd Expense restated Q2 2019 · Jun 30, 2018 $11.02M
Rd Expense restated Q2 2019 · Jun 30, 2018 $25.07M
Net Income Q2 2019 · Jun 30, 2019 −$19.43M
Net Income Q2 2019 · Jun 30, 2019 −$38.39M
Net Income Q2 2019 · Mar 31, 2019 −$18.96M
Net Income Q2 2019 · Jun 30, 2018 −$17.2M
Net Income Q2 2019 · Jun 30, 2018 −$37.79M
Net Income Q2 2019 · Mar 31, 2018 −$20.59M
Operating Income Q2 2019 · Jun 30, 2019 −$21.04M
Operating Income Q2 2019 · Jun 30, 2019 −$41.67M
Operating Income Q2 2019 · Jun 30, 2018 −$18.56M
Operating Income Q2 2019 · Jun 30, 2018 −$40.38M
Revenue Q2 2019 · Jun 30, 2019 $0
Revenue Q2 2019 · Jun 30, 2019 $0
Revenue Q2 2019 · Jun 30, 2018 $0
Revenue Q2 2019 · Jun 30, 2018 $0
Short Term Debt Q2 2019 · Dec 31, 2018 $131K